B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV

Johannes F. Scheid(Broad Institute), Ramnik J. Xavier(Massachusetts General Hospital), Betsabeh Khoramian Tusi(Stratasys (Israel)), Alexander A. Cohen(California Institute of Technology), Daniel B. Graham(Broad Institute), Fadi Ghantous(Beth Israel Deaconess Medical Center), Takuya Tada(New York University), Nathaniel R. Landau(New York University), Deborah T. Hung(Broad Institute), Christopher O. Barnes(Chan Zuckerberg Initiative (United States)), Sung‐Moo Park(Broad Institute), Priyanthi N.P. Gnanapragasam(California Institute of Technology), Paul D. Bieniasz(Rockefeller University), Ann E. Woolley(Evidence (Italy)), Michael A. Durney(Broad Institute), Kathryn E. Huey‐Tubman(California Institute of Technology), Pamela J. Björkman(California Institute of Technology), Orit Rozenblatt–Rosen(Broad Institute), Jennifer R. Keeffe(California Institute of Technology), Theodora Hatziioanno(Rockefeller University), Andrew Hudak(Broad Institute), Xiebin Gu(Broad Institute), Toni Delorey(Broad Institute), Michael S. Seaman(Beth Israel Deaconess Medical Center), Lisa A. Cosimi(Brigham and Women's Hospital), Jacques Deguine(Broad Institute), Anthony P. West(California Institute of Technology), Yiska Weisblum(Rockefeller University), Basak Eraslan(Broad Institute), Lindsey R. Baden(Brigham and Women's Hospital), Kara M. Rzasa(Broad Institute), Shuting Zhang(Broad Institute), Eric Brown(Broad Institute), Devan Phillips(Broad Institute), Frauke Muecksch(Heidelberg University), Aviv Regev(Broad Institute)
Cell
April 24, 2021
Cited by 99


Related Papers